| Typicality: | 0.378 |
| Saliency: | 0.301 |
| risk → be associated with → clinical trials | 10 |
| risk → be associated with → enrollment of clinical trials | 5 |
| risk → be related to → the completion of clinical trials | 5 |
| negative | neutral | positive |
| 0.441 | 0.534 | 0.025 |
| Raw frequency | 20 |
| Normalized frequency | 0.301 |
| Modifier score | 0.500 |
| Perplexity | 45.159 |